- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05547217
Gamification of Neurorehabilitation-centric Hand Exercises Post Stroke or Brain Injury
March 31, 2023 updated by: IRegained Inc.
Stroke is the leading cause of adult disability worldwide.
Often, severe neurological deficits occur after a stroke and roughly 70% of all stroke survivors have some form of hand function disability.
To improve the lives of those with hand function disability, IRegained Inc. has created the MyHandTM System.
The MyHandTM System is a smart-mechatronic device programmed with proprietary hand function training regiments (protocols) based on deep research in neuroplasticity.
It provides a highly unique and targeted approach to hand function rehabilitation with the help of the aforementioned protocols delivered with gamified training techniques.
The gamified format of the protocols allows for better patient engagement, thus allowing for more effective and efficient therapy.
Individuals who have sustained a stroke 5 months or earlier (considered to be chronic stroke survivors) will be eligible to participate in this study.
Participants will undergo a 2-hour training session, 2-3 days per week, over 12 weeks, for a total of 30 sessions.
Hand function therapy will be administered in a specific and gamified manner to enhance rehabilitation of the hand and provide participants with greater opportunity to regain hand function over the course of the study.
The goal of this research project is to understand how a gamified approach to hand function rehabilitation impacts engagement and motivation.
This understanding will directly translate into the development of more efficient and effective modes of therapy.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amy Doan, PhD Student
- Phone Number: 2351 705-675-1151
- Email: adoan@laurentian.ca
Study Locations
-
-
Ontario
-
Sudbury, Ontario, Canada, P3E 2C6
- Recruiting
- Laurentian University
-
Contact:
- Amy Doan, PhD
- Phone Number: 2351 705-675-1151
- Email: adoan@laurentian.ca
-
Principal Investigator:
- Amy Doan, PhD Student
-
Principal Investigator:
- Ratvinder Grewal, PhD
-
Sub-Investigator:
- Vineet Johnson, PhD (c)
-
Sub-Investigator:
- Mikayla Marshall, HBSc
-
Sub-Investigator:
- Eric Dumais, HBSc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Sustained a single stroke
Exclusion Criteria:
- Severe spasticity or contractures (2 or less in the CMSA) or any other musculoskeletal or neuromuscular disorders that compromise sensation or other neuromuscular parameters will be excluded from the study. Prospective participants who are incapable of providing consent to participate in the research study will also be excluded (determined by an MMSE score of 23 or less).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Neurorehabilitation of the Hand
Participants will undergo a 2-hour training session, 2-3 days per week, over 12 weeks, for a total of 30 sessions.
Hand function therapy will be administered in a specific and gamified manner to enhance rehabilitation of the hand and provide participants with greater opportunity to regain hand function over the course of the study.
|
The MyHandTM System is a smart-mechatronic device programmed with proprietary hand function training regiments (protocols) based on deep research in neuroplasticity.
It provides a highly unique and targeted approach to hand function rehabilitation with the help of the aforementioned protocols delivered with gamified training techniques.
The gamified format of the protocols allows for better patient engagement, thus allowing for more effective and efficient therapy.
Participants will undergo a 2-hour training session, 2-3 days per week, over 12 weeks, for a total of 30 sessions.
Hand function therapy will be administered in a specific and gamified manner to enhance rehabilitation of the hand and provide participants with greater opportunity to regain hand function over the course of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the Chedoke Arm and Hand Activity Inventory -9 (CAHAI-9)- Change is being assessed
Time Frame: Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
a 9-item assessment, will be performed by a trained clinician to estimate a participants functional ability during the initial assessment.
The CAHAI-9 requires a participant to perform 9 bimanual ADLs, each of which will be scored on a 7 point scale.
|
Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
Box and Block Test- Change is being assessed
Time Frame: Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
The BBT requires participants to move cubical wooden blocks over a partition from one box to another.
Grip and pinch dynamometry will be used to assess a participant's hand strength.
|
Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
The Motor Activity Log- Change is being assessed
Time Frame: Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
Estimates how much and how well a participant is able to use their affected upper limb.
The MAL is a 30 item questionnaire administered in through a semi-structured interview between the participant and a trained clinician.
|
Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
the NASA-Task Load Index (NASA-TLX)- Change is being assessed
Time Frame: After each treatment session
|
an assessment tool used to evaluate a participants perceived cognitive load during a session.
The NASA-TLX has six sub-scales; mental demand, temporal demand, frustration, performance, effort and physical demand.
The NASA-TLX scores, time taken to complete a level, game score and verbal language references made during gameplay will be used to estimate engagement.
|
After each treatment session
|
European Quality of Life Five Dimension Questionnaire (EQ-5D)- Change is being assessed
Time Frame: Baseline- before beginning the treatment and Post treatment- after the conclusion of 30 treatment sessions
|
To measure participants perceived quality of life through a questionnaire.
|
Baseline- before beginning the treatment and Post treatment- after the conclusion of 30 treatment sessions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Finger Goniometry- Change is being assessed
Time Frame: Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
estimate range of motion (ROM) of the various finger joints.
|
Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
Grip Dynamometry- Change is being assessed
Time Frame: Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
Measures participants grip strength
|
Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
Pinch Dynamometry- Change is being assessed
Time Frame: Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
Measures participants pinch strength
|
Baseline- before beginning the treatment, INTRA- after the completion of 15 treatment sessions and Post treatment- after the conclusion of 30 treatment sessions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 19, 2022
Primary Completion (Anticipated)
September 19, 2023
Study Completion (Anticipated)
September 19, 2023
Study Registration Dates
First Submitted
September 14, 2022
First Submitted That Met QC Criteria
September 19, 2022
First Posted (Actual)
September 21, 2022
Study Record Updates
Last Update Posted (Actual)
April 3, 2023
Last Update Submitted That Met QC Criteria
March 31, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUSUON0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Hand Therapy using the MyHand System
-
IRegained Inc.McMaster University; BaycrestRecruiting
-
IRegained Inc.McMaster University; BaycrestCompleted
-
IRegained Inc.Laurentian University; Health Sciences NorthCompleted
-
Hamilton Health Sciences CorporationNot yet recruiting
-
IRCCS San Camillo, Venezia, ItalyCompleted
-
University Hospital Inselspital, BerneTerminatedAge-related Macular Degeneration | Macular Edema | Retinal Vein Occlusion | Central Serous Chorioretinopathy | Retinal NeovascularizationSwitzerland
-
Cerephex CorporationCompleted
-
Alexandria UniversityCompleted
-
Duke UniversityGenzyme, a Sanofi CompanyRecruitingLate-Onset Pompe Disease | Lysosomal DiseaseUnited States
-
Medical University of GrazMenarini GroupCompleted